Trial Outcomes & Findings for Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes (NCT NCT03244722)
NCT ID: NCT03244722
Last Updated: 2026-09-04
Results Overview
Primary pre-specified outcome is BMI change (kg/m2) after dietary intervention. Trained staff will measure height and weight to the nearest .1cm and .1kg using a wall-mounted, precision stadiometer and calibrated digital scale. BMI will be calculated (kg/m2).
COMPLETED
NA
147 participants
Baseline to conception (up to 68 weeks post enrollment)
2026-09-04
Participant Flow
Participant milestones
| Measure |
Obese - Very Low Energy Diet (VLED)
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Overall Study
STARTED
|
49
|
45
|
53
|
|
Overall Study
COMPLETED
|
22
|
27
|
35
|
|
Overall Study
NOT COMPLETED
|
27
|
18
|
18
|
Reasons for withdrawal
| Measure |
Obese - Very Low Energy Diet (VLED)
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Overall Study
Did not become pregnant within 12 month window
|
13
|
6
|
10
|
|
Overall Study
Withdrawal by Subject
|
7
|
3
|
2
|
|
Overall Study
Lost to Follow-up
|
3
|
4
|
2
|
|
Overall Study
Removed from study by NIH, due to inadequate time for post-conception follow-up before study end
|
4
|
5
|
4
|
Baseline Characteristics
Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
Baseline characteristics by cohort
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
Total
n=84 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=23 Participants
|
0 Participants
n=23 Participants
|
34 Participants
n=22 Participants
|
37 Participants
n=21 Participants
|
|
Age, Continuous
|
31.8 years
STANDARD_DEVIATION 4.1 • n=23 Participants
|
32.1 years
STANDARD_DEVIATION 3.4 • n=23 Participants
|
31.0 years
STANDARD_DEVIATION 4.0 • n=22 Participants
|
31.6 years
STANDARD_DEVIATION 3.8 • n=21 Participants
|
|
Sex: Female, Male
Female
|
22 Participants
n=23 Participants
|
27 Participants
n=23 Participants
|
35 Participants
n=22 Participants
|
84 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=23 Participants
|
0 Participants
n=23 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
19 Participants
n=23 Participants
|
27 Participants
n=23 Participants
|
1 Participants
n=22 Participants
|
47 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=23 Participants
|
0 Participants
n=23 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race/Ethnicity, Customized
White
|
19 Participants
n=23 Participants
|
21 Participants
n=23 Participants
|
30 Participants
n=22 Participants
|
70 Participants
n=21 Participants
|
|
Race/Ethnicity, Customized
Black
|
1 Participants
n=23 Participants
|
3 Participants
n=23 Participants
|
1 Participants
n=22 Participants
|
5 Participants
n=21 Participants
|
|
Race/Ethnicity, Customized
Other
|
2 Participants
n=23 Participants
|
3 Participants
n=23 Participants
|
4 Participants
n=22 Participants
|
9 Participants
n=21 Participants
|
|
Region of Enrollment
United States
|
22 Participants
n=23 Participants
|
27 Participants
n=23 Participants
|
35 Participants
n=22 Participants
|
84 Participants
n=21 Participants
|
PRIMARY outcome
Timeframe: Baseline to conception (up to 68 weeks post enrollment)Primary pre-specified outcome is BMI change (kg/m2) after dietary intervention. Trained staff will measure height and weight to the nearest .1cm and .1kg using a wall-mounted, precision stadiometer and calibrated digital scale. BMI will be calculated (kg/m2).
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Preconception Weight Loss
BMI at conception
|
31.0 kg/m2
Standard Deviation 3.6
|
35.0 kg/m2
Standard Deviation 4.5
|
23.1 kg/m2
Standard Deviation 1.9
|
|
Preconception Weight Loss
Baseline (preconception) BMI
|
35.0 kg/m2
Standard Deviation 2.9
|
35.9 kg/m2
Standard Deviation 4.3
|
23.2 kg/m2
Standard Deviation 1.8
|
PRIMARY outcome
Timeframe: Throughout pregnancy (up to 108 weeks post enrollment)Gestational diabetes or hypertensive disorders in pregnancy
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Maternal Diagnosis
Hypertension
|
6 Participants
|
11 Participants
|
3 Participants
|
|
Maternal Diagnosis
Gestational Diabetes
|
1 Participants
|
3 Participants
|
3 Participants
|
PRIMARY outcome
Timeframe: Delivery (up to 108 weeks post enrollment)Percentage body fat (adiposity) in the offspring of women randomized to Very Low Energy Diet (VLED) compared to those randomized to Standard of Care (SOC). Body composition will be assessed by PeaPod (fat mass in grams).
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Offspring Body Fat Mass
|
15.7 percent body fat
Standard Deviation 3.5
|
11.6 percent body fat
Standard Deviation 4.0
|
13.2 percent body fat
Standard Deviation 6.4
|
SECONDARY outcome
Timeframe: 2nd trimester (up to 90 weeks post enrollment) and 3rd trimester (up to 102 weeks post enrollment) of pregnancyPopulation: These are the number of women who conceived spontaneously and had full term singleton pregnancy
Abdominal circumference (cm) will be assessed through ultrasound to determine fetal growth.
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Fetal Growth Will be Assessed by Ultrasound
2nd Trimester
|
12.9 cm
Standard Deviation 2.8
|
13.2 cm
Standard Deviation 2.5
|
13.0 cm
Standard Deviation 2.2
|
|
Fetal Growth Will be Assessed by Ultrasound
3rd Trimester
|
30.89 cm
Standard Deviation 2.62
|
30.83 cm
Standard Deviation 2.57
|
30.07 cm
Standard Deviation 2.27
|
SECONDARY outcome
Timeframe: Delivery (up to 108 weeks post enrollment) up to 12 month post delivery follow-up (up to 160 weeks post enrollment)Population: All data collected is presented. Not all participants attended 12 month appointment at which time data is collected
Trained staff will measure infant length and weight to the nearest .1cm and .1kg using an infant length board and digital infant scale. Ponderal index will be calculated and used to assess growth from baseline to 12 months post birth. Ponderal index is weight/length (grams/cubic centimeters).
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Ponderal Index
Delivery
|
2.8 g/cm3
Standard Deviation 0.3
|
2.8 g/cm3
Standard Deviation 0.9
|
2.5 g/cm3
Standard Deviation 0.3
|
|
Ponderal Index
12 months
|
2.20 g/cm3
Standard Deviation 0.18
|
2.31 g/cm3
Standard Deviation 0.24
|
2.17 g/cm3
Standard Deviation 0.19
|
SECONDARY outcome
Timeframe: Delivery (up to 108 weeks post enrollment)Categorical as caesarean or vaginal delivery
Outcome measures
| Measure |
Obese - Very Low Energy Diet (VLED)
n=22 Participants
Participants will adopt a very-low energy diet Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=27 Participants
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=35 Participants
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Mode of Delivery
Caesarean delivery
|
10 Participants
|
9 Participants
|
8 Participants
|
|
Mode of Delivery
Vaginal delivery
|
12 Participants
|
18 Participants
|
27 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Throughout pregnancyCategorical as miscarriage, intrauterine growth restriction (IUGR), fetal demise, fetal anomalies
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: DeliveryMultivariate computational models will assess the association of maternal and neonate metabolite to fetal growth and newborn weight (g) and adiposity (g).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: DeliveryThe maternal metabolome (\~metabolites) will be related to neonate adiposity, gestational weight gain, pregnancy complications, and intrauterine fetal growth rate.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: DeliveryDifferences in site-specific DNA methylation (\~450,000 sites) in offspring cord blood mononuclear cells between the Standard of Care (SOC), Very Low Energy Diet (VLED) and lean groups will be assessed.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, 12 month follow-upHealth-related quality-of-life and other behavioral assessments based on validated survey instruments
Outcome measures
Outcome data not reported
Adverse Events
Obese - Very Low Energy Diet (VLED)
Obese - Standard of Care (SOC)
LEAN
Serious adverse events
| Measure |
Obese - Very Low Energy Diet (VLED)
n=49 participants at risk
Participants will adopt a very-low energy diet
Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=45 participants at risk
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet
Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=53 participants at risk
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Hepatobiliary disorders
gallstones
|
4.1%
2/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Cardiac disorders
supraventricular tachycardia
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • Number of events 3 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
fetal hydrops
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • Number of events 1 • up to 3.5 years
|
Other adverse events
| Measure |
Obese - Very Low Energy Diet (VLED)
n=49 participants at risk
Participants will adopt a very-low energy diet
Very-low energy Diet (VLED): Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline x 12 weeks with 4 week period of transition to low calorie food based diet prior to conceiving.
|
Obese - Standard of Care (SOC)
n=45 participants at risk
Participants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet
Standard of care (SOC): Standard consultation with a registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss of \~5% prior to conceiving.
|
LEAN
n=53 participants at risk
Healthy weight women followed in parallel. No dietary intervention prior to conceiving.
|
|---|---|---|---|
|
Pregnancy, puerperium and perinatal conditions
Fall (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
4.4%
2/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Vaginal bleeding (during pregnancy)
|
2.0%
1/49 • up to 3.5 years
|
4.4%
2/45 • up to 3.5 years
|
3.8%
2/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Pregnancy loss
|
0.00%
0/49 • up to 3.5 years
|
4.4%
2/45 • up to 3.5 years
|
3.8%
2/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
High blood pressure (gestational hypertension)
|
12.2%
6/49 • up to 3.5 years
|
24.4%
11/45 • up to 3.5 years
|
5.7%
3/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Concerns of high blood pressure with normal blood pressures in ED (during pregnancy)
|
4.1%
2/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Superficial burn to arm (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Gestational Diabetes
|
2.0%
1/49 • up to 3.5 years
|
6.7%
3/45 • up to 3.5 years
|
5.7%
3/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Decreased fetal movement with reassuring nonstress test (during pregnancy)
|
2.0%
1/49 • up to 3.5 years
|
4.4%
2/45 • up to 3.5 years
|
13.2%
7/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Contractions without being in labor
|
0.00%
0/49 • up to 3.5 years
|
8.9%
4/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Heart palpitations or tachycardia (during pregnancy)
|
2.0%
1/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
3.8%
2/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Chest pressure with normal investigation in ED
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Norovirus gastroenteritis (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Bat exposure (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Nausea and vomiting (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
3.8%
2/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Headache (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
6.7%
3/45 • up to 3.5 years
|
3.8%
2/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Syncope (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Mycotic vaginal infection (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Back pain (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
4.4%
2/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Kidney stone (renal calculus) (during pregnancy)
|
0.00%
0/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Perirectal abscess (postpartum)
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Mastocystitis
|
0.00%
0/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
1.9%
1/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Postpartum vaginal bleeding
|
2.0%
1/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Pregnancy, puerperium and perinatal conditions
Joint pain and swelling (postpartum)
|
0.00%
0/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Skin and subcutaneous tissue disorders
Rash
|
2.0%
1/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Musculoskeletal and connective tissue disorders
Leg pain with normal investigation
|
2.0%
1/49 • up to 3.5 years
|
0.00%
0/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
|
Eye disorders
Visual disturbance
|
0.00%
0/49 • up to 3.5 years
|
2.2%
1/45 • up to 3.5 years
|
0.00%
0/53 • up to 3.5 years
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place